معرفی
Petra Ettema is a Researcher at the University of Groningen's Faculty of Science and Engineering within the Department of Chemical and Pharmaceutical Biology. Her work focuses on developing molecular inhibitors targeting key enzymes involved in inflammatory diseases and cancer pathogenesis.
Her research spans cancer biology, inflammation mechanisms, and drug discovery, with expertise in 15-lipoxygenase-1 (15-LOX-1), macrophage migration inhibitory factor (MIF), and D-dopachrome tautomerase (D-DT). She investigates how these targets regulate ferroptosis, DNA repair, and tumor proliferation, particularly in non-small cell lung cancer. Her approach integrates medicinal chemistry and molecular pharmacology to design novel therapeutics, emphasizing dual-targeting strategies for enhanced efficacy.
Analysis of her recent publications reveals a dominant focus on exploiting cell death pathways (especially ferroptosis) and DNA repair vulnerabilities in cancer. Her work demonstrates consistent innovation in synthesizing small-molecule inhibitors, with increasing emphasis on combinatorial targeting approaches since 2023. Key trends include the development of triazole-based compounds and thienopyrimidine derivatives that modulate redox signaling and inflammatory cascades.
Ettema actively collaborates within Professor Frank J. Dekker's research group, contributing to projects that bridge biochemical mechanism studies with therapeutic applications. Her work directly supports UN Sustainable Development Goal 3 (Good Health and Well-being) through advancements in targeted cancer therapies and anti-inflammatory drug development.
